跳至主要内容
临床试验/NCT04732143
NCT04732143终止不适用

The Effect of Preoperative Inspiratory Muscle Training Using Incentive Spirometer on Postoperative Pulmonary Complications Following Lung Resection

Milton S. Hershey Medical Center2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2021年4月27日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
25
试验地点
2
主要终点
Atelectasis

研究概览

简要总结

The objective of this study is to demonstrate that inspiratory muscle training with daily use of an incentive spirometer for at least 14 days prior to lung surgery will reduce the risk of post-operative pulmonary complications.

详细描述

Postoperative pulmonary complications (PPC) are the most common adverse events following lung resection, with a reported incidence of over 20-30% in some series. The objective of this study is to demonstrate that inspiratory muscle training (IMT) with daily use of an incentive spirometer (IS) for at least 14 days prior to lung surgery will reduce the risk of PPCs compared to the usual care, consisting of no formal preoperative IMT. The hypothesis is that preoperative inspiratory spirometer breathing (ISB) is a feasible and cost-effective intervention that can significantly reduce PPCs after lung resection. It is also hypothesized that patient compliance with the intervention will be high because of its simplicity, convenience, low cost and no potential for adverse effects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ECOG performance status score 2 or less
  • Undergoing elective lung resection (includes wedge resection, lobectomy, bi-lobectomy, pneumonectomy, sleeve resection) via minimally invasive (VATS or robotic) approach or thoracotomy
  • Chest wall resection if performed concurrently with lung resection

排除标准

  • ECOG performance status score greater than 2
  • Significant cognitive impairment preventing informed consent
  • Non-English speaking
  • Wedge biopsy for interstitial lung disease
  • Bullectomy for bullous emphysema
  • Pre-existing tracheostomy
  • Emergent or urgent surgery
  • Preoperative home oxygen use
  • History of neuromuscular disease
  • Prisoners

结局指标

主要结局

Atelectasis

时间窗: Through completion of follow-up (30 days)

Incidence of atelectasis requiring bronchoscopy or additional bedside therapy by a respiratory therapist

Respiratory failure

时间窗: Through completion of follow-up (30 days)

Incidence of respiratory failure requiring re-intubation or high flow nasal cannula and/or non-invasive positive pressure ventilation

Pneumonia

时间窗: Through completion of follow-up (30 days)

Clinical and/or radiographic evidence of pneumonia requiring antibiotic therapy

Pneumothorax or subcutaneous emphysema

时间窗: Through completion of follow-up (30 days)

Incidence of clinically significant pneumothorax or subcutaneous emphysema requiring intervention or extended hospital admission for observation

Cardiac arrhythmia

时间窗: Through completion of follow-up (30 days)

Incidence of cardiac arrhythmia requiring intervention (e.g. atrial fibrillation, supraventricular tachycardia, etc.)

Pleural effusion

时间窗: Through completion of follow-up (30 days)

Incidence of pleural effusion requiring drainage or other medical intervention (e.g. use of diuretics)

Prolonged air leak

时间窗: Through completion of follow-up (30 days)

Incidence of prolonged air leak (\>5 days) or requiring discharge with chest tube

Need for supplemental oxygen

时间窗: Through completion of follow-up (30 days)

Incidence of patients requiring supplemental oxygen upon discharge

Empyema/bronchopleural fistula

时间窗: Through completion of follow-up (30 days)

Incidence of empyema and/or bronchopleural fistula confirmed by fluid analysis and/or cultures

次要结局

  • ICU length of stay(Through completion of follow-up (30 days))
  • Change from baseline in dyspnea, measured by the modified Medical Research Council scale(Baseline, 2 weeks and 4 weeks after surgery)
  • Hospital length of stay(Through completion of follow-up (30 days))
  • Chest tube duration(Through completion of follow-up (30 days))
  • Mortality(Through completion of follow-up (30 days))
  • Hospital readmission(Through completion of follow-up (30 days))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Pauline Go

Associate Professor of Surgery

Milton S. Hershey Medical Center

研究点 (2)

Loading locations...

相似试验